1. Clinical Overview
Clotrimazole is a broad-spectrum synthetic imidazole antifungal agent used primarily for the topical treatment of superficial fungal infections. It acts by inhibiting ergosterol synthesis, a critical component of fungal cell membranes, leading to increased membrane permeability and cell death. In the Indian context, it is a first-line, widely available, and cost-effective treatment for vulvovaginal candidiasis (VVC) and other dermatomycoses.
| Onset | Duration | Bioavailability |
|---|---|---|
| Symptomatic relief typically begins within 24-72 hours of topical application. | The local antifungal effect persists for the duration of the treatment course (typically 3-7 days for vaginal use). Systemic absorption is negligible. | Negligible (<0.5%) following topical or vaginal administration due to minimal systemic absorption. |
2. Mechanism of Action
Clotrimazole is a fungistatic and fungicidal agent. It inhibits the fungal cytochrome P450-dependent enzyme lanosterol 14-α-demethylase. This inhibition blocks the conversion of lanosterol to ergosterol, an essential sterol component of the fungal cell membrane.
3. Indications & Uses
- Vulvovaginal Candidiasis (Vaginal Thrush)
- Cutaneous Dermatophytosis (Ringworm, Tinea corporis/cruris/pedis)
- Cutaneous Candidiasis (Intertrigo)
- Pityriasis Versicolor (Tinea versicolor)
4. Dosage & Administration
Adult Dosage: Vaginal: 100mg intravaginally once daily at bedtime for 6-7 days, or a single 500mg dose (different formulation). Topical: Apply a thin layer to affected area 2-3 times daily for 2-4 weeks.
Administration: Vaginal Tablet: Use applicator for insertion high into the vagina at bedtime. Wash hands before and after. Topical: Clean and dry area thoroughly before application. Gently rub in a thin layer. Wash hands after application unless hands are being treated.
5. Side Effects
Common side effects may include:
- Local burning or stinging sensation (topical/vaginal)
- Vaginal itching or irritation
- Skin erythema or mild rash at application site
- Abdominal cramps (vaginal use)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Amphotericin B | Potential antagonistic antifungal effect in vitro; clinical significance for topical use is minimal. | Moderate |
| CYP3A4 Substrates (e.g., Cyclosporine, Tacrolimus) | Theoretical interaction if significant systemic absorption occurs; unlikely with topical/vaginal use. | Minor |
| Vaginal Spermicides (e.g., Nonoxynol-9) | May inactivate clotrimazole; avoid concurrent use with vaginal formulations. | Moderate |
7. Patient Counselling
- DO complete the full course of treatment even if symptoms improve earlier.
- DO wear loose, cotton underwear during treatment for vaginal infections.
- DO keep the affected skin areas clean and dry.
- DONT engage in sexual intercourse during vaginal treatment (or partner should use condom as cream may damage latex).
- DONT use tampons, douches, or other vaginal products concurrently.
- DONT apply to eyes, mouth, or deep open wounds.
8. Toxicology & Storage
Overdose: Topical/Vaginal: Not expected from topical use. Accidental oral ingestion of vaginal/cream formulations may cause nausea, vomiting, diarrhea, and abdominal pain. Significant systemic overdose is improbable.
Storage: Store below 30°C. Protect from light and moisture. Keep out of reach of children. Do not freeze.